Tevogen (TVGN) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $7.07, -0.14% vs the prior close of $7.08.
- Volume 2.30K shares, 0.3x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
TVGN ends flat (-0.1%) to $7.07. Closed at $7.07, -0.14% vs the prior close of $7.08. Day range $6.75–$7.07, opened at $6.90.
TVGN daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — TVGN ends flat (-0.1%) to $7.07
- Closed at $7.07, -0.14% vs the prior close of $7.08. Day range $6.75–$7.07, opened at $6.90.
- Volume was 2.30K shares, 0.3x its 50-day average of 7.12K — lighter than usual.
- Price is +1.1% vs its 50-day average ($6.99) and -19.2% vs its 200-day average ($8.75).
- 52-week range $3.64–$39.00; today's close sits at 10% of that range, 81.9% below the 52-week high.
Oct 15, 2026 — TVGN jumps 8.8% to $7.08
- Closed at $7.08, +8.82% vs the prior close of $6.51. Day range $6.38–$7.09, opened at $6.38.
- Volume was 1.50K shares, 0.2x its 50-day average of 7.34K — lighter than usual.
- Price is +1.4% vs its 50-day average ($6.98) and -19.6% vs its 200-day average ($8.80).
- 52-week range $3.64–$39.00; today's close sits at 10% of that range, 81.8% below the 52-week high.
Oct 14, 2026 — TVGN slides 8.5% to $6.51
- Closed at $6.51, -8.50% vs the prior close of $7.11. Day range $6.41–$7.10, opened at $6.77.
- Volume was 2.50K shares, 0.3x its 50-day average of 7.47K — lighter than usual.
- Price is -6.7% vs its 50-day average ($6.97) and -26.5% vs its 200-day average ($8.85).
- 52-week range $3.64–$39.00; today's close sits at 8% of that range, 83.3% below the 52-week high.
Oct 13, 2026 — TVGN jumps 6.5% to $7.11
- Closed at $7.11, +6.45% vs the prior close of $6.68. Day range $6.50–$7.11, opened at $6.57.
- Volume was 4.30K shares, 0.6x its 50-day average of 7.80K — lighter than usual.
- Price is +1.8% vs its 50-day average ($6.98) and -20.2% vs its 200-day average ($8.92).
- 52-week range $3.64–$39.00; today's close sits at 10% of that range, 81.8% below the 52-week high.
Oct 12, 2026 — TVGN dips 1.5% to $6.68
- Closed at $6.68, -1.49% vs the prior close of $6.78. Day range $6.42–$6.99, opened at $6.99.
- Volume was 3.40K shares, 0.4x its 50-day average of 7.95K — lighter than usual.
- Price is -4.3% vs its 50-day average ($6.98) and -25.6% vs its 200-day average ($8.98).
- 52-week range $3.64–$39.00; today's close sits at 9% of that range, 82.9% below the 52-week high.
Oct 9, 2026 — TVGN slides 4.0% to $6.78
- Closed at $6.78, -3.97% vs the prior close of $7.06. Day range $6.78–$7.15, opened at $7.15.
- Volume was 2.70K shares, 0.3x its 50-day average of 8.38K — lighter than usual.
- Price is -3.0% vs its 50-day average ($6.99) and -25.0% vs its 200-day average ($9.04).
- 52-week range $3.64–$39.00; today's close sits at 9% of that range, 82.6% below the 52-week high.
Oct 8, 2026 — TVGN jumps 8.8% to $7.06 on 3.8x normal volume
- Closed at $7.06, +8.78% vs the prior close of $6.49. Day range $5.87–$7.43, opened at $6.68.
- Volume was 30.20K shares, 3.8x its 50-day average of 8.02K — unusually heavy trading.
- Price is +1.0% vs its 50-day average ($6.99) and -22.4% vs its 200-day average ($9.10).
- 52-week range $3.64–$39.00; today's close sits at 10% of that range, 81.9% below the 52-week high.
Oct 7, 2026 — TVGN ends flat (+0.0%) to $6.49, 3 down days in a row
- Closed at $6.49, +0.00% vs the prior close of $6.49. Day range $6.49–$7.10, opened at $7.10.
- Volume was 1.80K shares, 0.2x its 50-day average of 8.44K — lighter than usual.
- Price is -6.8% vs its 50-day average ($6.97) and -29.2% vs its 200-day average ($9.16).
- 52-week range $3.64–$39.00; today's close sits at 8% of that range, 83.4% below the 52-week high.
- That makes 3 straight losses.
Oct 6, 2026 — TVGN dips 1.7% to $6.49, a 1-month low
- Closed at $6.49, -1.67% vs the prior close of $6.60. Day range $6.46–$6.56, opened at $6.56.
- Volume was 2.80K shares, 0.3x its 50-day average of 8.79K — lighter than usual.
- Price is -6.6% vs its 50-day average ($6.95) and -29.6% vs its 200-day average ($9.22).
- 52-week range $3.64–$39.00; today's close sits at 8% of that range, 83.4% below the 52-week high.
Oct 5, 2026 — TVGN slides 5.4% to $6.60, a 1-month low
- Closed at $6.60, -5.44% vs the prior close of $6.98. Day range $6.57–$6.97, opened at $6.90.
- Volume was 3.50K shares, 0.4x its 50-day average of 8.89K — lighter than usual.
- Price is -4.8% vs its 50-day average ($6.93) and -28.9% vs its 200-day average ($9.28).
- 52-week range $3.64–$39.50; today's close sits at 8% of that range, 83.3% below the 52-week high.
Oct 2, 2026 — TVGN jumps 3.9% to $6.98
- Closed at $6.98, +3.87% vs the prior close of $6.72. Day range $6.59–$7.01, opened at $6.59.
- Volume was 1.60K shares, 0.2x its 50-day average of 9.02K — lighter than usual.
- Price is +1.3% vs its 50-day average ($6.89) and -25.3% vs its 200-day average ($9.35).
- 52-week range $3.64–$39.85; today's close sits at 9% of that range, 82.5% below the 52-week high.
TVGN latest news & SEC filings
Every SEC filing by or about TVGN in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 30, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Sep 16, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 16, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 16, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Saadi Ryan H. received an award of 8,000,000 shares on Sep 14, 2026; now holds 11,705,689
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 16, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Desai Kirti received an award of 750,000 shares on Sep 14, 2026; now holds 992,983
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 16, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Sep 15, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 15, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 15, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 15, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 10, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Aug 26, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 5.03 — Amended its charter or bylaws / changed fiscal year.
- Item 5.07 — Reported shareholder vote results.
Aug 24, 2026 · Form S-8 — Employee share plan registration
Registration of shares for employee stock plans (S-8)
Aug 14, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$5.76M (prior year -$5.50M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$1.52 (prior year -$1.71) (loss narrowed vs Jun 30, 2025)
Aug 3, 2026 · Form DEF 14A — Proxy statement
Proxy statement — agenda for the shareholder meeting (board elections, executive pay, votes)
Things to know before you trade TVGN
- Last results release: Apr 26, 2024 (8-K Item 2.02).
- How much it moves: over the last 20 sessions the average daily move was 3.88% (largest 8.8%). That is a volatile stock.
- Liquidity: about 4.75K shares (≈$33.55K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $7.07 vs a range of $3.64–$39.00 (10% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:50 on Mar 6, 2026
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 12 sales; latest: Neal Flomenberg sold 501 shares on Mar 13, 2026.
- Latest filings: 8-K Sep 30, 2026; 8-K Sep 16, 2026; 8-K Sep 10, 2026.
- Share count: 6.51M shares outstanding (Aug 10, 2026), -96.7% vs a year earlier — the company has been reducing its share count.
- Listing: Nasdaq · industry: Biological Products, (No Diagnostic Substances).
TVGN market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 6.90 | 7.07 | 6.75 | 7.07 | 2.30K |
| Oct 15, 2026 | 6.38 | 7.09 | 6.38 | 7.08 | 1.50K |
| Oct 14, 2026 | 6.77 | 7.10 | 6.41 | 6.51 | 2.50K |
| Oct 13, 2026 | 6.57 | 7.11 | 6.50 | 7.11 | 4.30K |
| Oct 12, 2026 | 6.99 | 6.99 | 6.42 | 6.68 | 3.40K |
| Oct 9, 2026 | 7.15 | 7.15 | 6.78 | 6.78 | 2.70K |
| Oct 8, 2026 | 6.68 | 7.43 | 5.87 | 7.06 | 30.20K |
| Oct 7, 2026 | 7.10 | 7.10 | 6.49 | 6.49 | 1.80K |
| Oct 6, 2026 | 6.56 | 6.56 | 6.46 | 6.49 | 2.80K |
| Oct 5, 2026 | 6.90 | 6.97 | 6.57 | 6.60 | 3.50K |
| Oct 2, 2026 | 6.59 | 7.01 | 6.59 | 6.98 | 1.60K |
| Oct 1, 2026 | 6.35 | 6.99 | 6.35 | 6.72 | 6.50K |
| Sep 30, 2026 | 6.57 | 7.23 | 6.57 | 6.62 | 1.70K |
| Sep 29, 2026 | 6.96 | 7.07 | 6.75 | 6.75 | 1.40K |
| Sep 28, 2026 | 7.44 | 7.50 | 6.76 | 6.76 | 15.60K |
| Sep 25, 2026 | 7.70 | 7.70 | 7.25 | 7.25 | 5.60K |
| Sep 24, 2026 | 7.44 | 7.85 | 7.04 | 7.85 | 2.90K |
| Sep 23, 2026 | 7.81 | 7.81 | 7.81 | 7.81 | 0 |
| Sep 22, 2026 | 7.58 | 7.81 | 7.43 | 7.81 | 2.80K |
| Sep 21, 2026 | 7.81 | 7.81 | 7.43 | 7.43 | 1.80K |
About Tevogen
Tevogen (TVGN) is listed on the Nasdaq and classified by the SEC under “Biological Products, (No Diagnostic Substances)”. Its business address is in WARREN, NJ. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1860871.
TVGN board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Jeffrey L. Feike | Director | Sep 15, 2026 |
| Keow Lin Goh | Director | Sep 15, 2026 |
| Susan M Podlogar | Director | Sep 15, 2026 |
| Curtis L. Patton | Director | Sep 15, 2026 |
| Ryan H. Saadi | Chief Executive Officer | Sep 16, 2026 |
| Victor J. Sordillo | Director | Sep 15, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Kirti Desai | Chief Financial Officer | Sep 16, 2026 |
| Neal Flomenberg | See Remarks | Mar 17, 2026 |
| Ryan H. Saadi | Chief Executive Officer | Sep 16, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Mar 13, 2026 | Neal Flomenberg | Sale | 501 | $6.40 |
| Mar 13, 2026 | Neal Flomenberg | Sale | 501 | $6.40 |
| Mar 13, 2026 | Neal Flomenberg | Sale | 501 | $6.40 |
| Mar 13, 2026 | Neal Flomenberg | Sale | 501 | $6.40 |
| Mar 11, 2026 | Neal Flomenberg | Sale | 452 | $7.26 |
| Mar 11, 2026 | Neal Flomenberg | Sale | 452 | $7.26 |
| Mar 11, 2026 | Neal Flomenberg | Sale | 452 | $7.26 |
| Mar 11, 2026 | Neal Flomenberg | Sale | 452 | $7.26 |
| Mar 10, 2026 | Neal Flomenberg | Sale | 19 | $7.75 |
| Mar 10, 2026 | Neal Flomenberg | Sale | 19 | $7.75 |
| Mar 10, 2026 | Neal Flomenberg | Sale | 19 | $7.75 |
| Mar 10, 2026 | Neal Flomenberg | Sale | 19 | $7.75 |
TVGN financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-26.28M | -8.08 | $-12.33M |
| Dec 31, 2024 | — | $-13.73M | -3.50 | $-12.00M |
| Dec 31, 2023 | — | $-60.48M | -2.44 | $-8.17M |
| Dec 31, 2022 | — | $4.41M | — | $-215.40K |
Latest balance sheet: total assets $4.73M, total liabilities $13.62M, cash $0 (as of Jun 30, 2026).
TVGN earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Apr 26, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Biological Products, (No Diagnostic Substances)
Moderna (MRNA)Amgen (AMGN)Gilead Sciences (GILD)Twist Bioscience (TWST)Revolution Medicines (RVMD)Argenx Se (ARGX)Kodiak Sciences (KOD)Greenland Mines (GRML)Halozyme Therapeutics (HALO)Biogen (BIIB)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on TVGN
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.